Product Overview
Amoxicillin and Clavulanate Potassium Tablets USP combine a broad-spectrum penicillin-class antibacterial agent with a beta-lactamase inhibitor to help treat susceptible bacterial infections. This formulation contains 875 mg of amoxicillin and 125 mg of clavulanic acid per tablet for oral administration.
The combination is designed to extend antibacterial activity against organisms that produce beta-lactamase enzymes. Supplied in bottles of 100 tablets, this prescription medication is commonly utilized in healthcare, clinic, and pharmacy settings.
Product Features
- Combination of amoxicillin and clavulanate potassium in a single oral tablet.
- Contains 875 mg amoxicillin and 125 mg clavulanic acid per tablet.
- Film-coated tablet for oral administration.
- Beta-lactamase inhibitor component helps expand antibacterial coverage.
- Packaged in a bottle of 100 tablets for convenient inventory management.
Product Specifications
| SKU/Catalog Number | MF-10190563 |
| Product Name | Amoxicillin and Clavulanate Potassium Tablets USP |
| Generic Name | Amoxicillin and Clavulanate Potassium |
| Strength | 875 mg / 125 mg |
| Dosage Form | Tablet |
| Route of Administration | Oral |
| Drug Class | Penicillin Antibiotic / Beta-Lactamase Inhibitor Combination |
| Active Ingredients | Amoxicillin 875 mg; Clavulanate Potassium equivalent to 125 mg Clavulanic Acid |
| Tablet Appearance | White to off-white, film-coated tablet |
| Package Configuration | Bottle of 100 Tablets |
| NDC Number | 42571-162-01 |
| Rx Status | Prescription Only |
| Manufacturer | Micro Labs Limited |
| Labeler | Micro Labs USA Inc. |
| Therapeutic Category | Antibacterial |
| Storage Requirement | Room Temperature — Store at 20–25°C |
| Container Requirement | Dispense in a tight, light-resistant container as recommended by manufacturer |
